ProKidney Corp. Marketable Securities
ProKidney Corp. (PROK) had Marketable Securities of $106.70 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets
us-gaap:MarketableSecurities · last filed 2026-08-10
- 2026-06-30: Marketable Securities $106.70M.
- 2026-03-31: Marketable Securities $123.05M.
- 2025-12-31: Marketable Securities $161.48M.
- 2025-09-30: Marketable Securities $176.40M.
| Period end | Marketable Securities |
|---|---|
| 2026-06-30 | $106.70M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $123.05M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $161.48M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $176.40M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $209.79M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $230.69M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $259.17M 10-K · filed 2026-03-18 |
| 2024-09-30 | $298.72M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $217.02M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $244.61M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $302.30M 10-K · filed 2025-03-17 |
| 2023-09-30 | $204.94M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $202.57M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $192.05M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-22 |